Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Deals

Returning to its roots, Amgen adding growth with $28.7B deal for Horizon 

Acquisition bolsters inflammation, autoimmune portfolio after oncology franchise comes under pressure

December 12, 2022 11:52 PM UTC

With sales flat and its push into cancer yet to yield any major growth drivers, Amgen’s $28.7 billion acquisition of Horizon Therapeutics marks a continuation of the large cap’s return to the inflammatory and autoimmune space where it’s been most commercially successful.

The deal is also the latest — and largest — move by Amgen Inc. (NASDAQ:AMGN) to add growth via acquisitions...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article